This website uses cookies to ensure you get the best experience on our website.
Privacy Statement

Pulmogine, the continuous output mode mesh nebulizer developed by Hcmed, introduces a novel customization platform for drug-nebulizer combination, delivering small molecule and biologic formulations.

NO MORE RESTRICTIONS FOR INHALED MEDICATIONS

  • Terbutaline Sulfate
    5 mg / 2 ml

    Delivered dose: 42%
    Delivery Rate: 580 µg/min
    MMAD: 4.85 µm
    FPF: 50.06 ± 0.91%

  • Fluticasone Propionate
    2 mg / 2 ml

    Delivered dose: 35%
    Delivery Rate: 130 µg/min
    DV50: 4.57 µm
    FPF: 54.68±3.61%

  • Interferon Beta-1b
    0.15 mg / 1ml

    Delivered dose: 46%
    Delivery Rate: 17.9 µg/min
    DV50: 4.21 µm
    FPF: 61.11±1.97%

Sources
  1. Drug Delivery to the Lungs, Volume 32, 2021 – E.H. Cuevas Brun et al.
  2. ONdrugDelivery – Pulmonary and Nasal Drug Delivery, Nov.2021
  3. Respiratory Drug Delivery 2022 – Cuevas Brun et al.

HCMED's CDMO Services include the customization of pulmogine mesh nebulizers to target specific output parameters for each formulation

Smaller MMAD, associated to higher FPF and FPD, ensures greater central and peripheral lung deposition.

Enhance drug delivery performance and achieve optimal results using our customization platform

Pulmogine® PROVIDES AFFORDABLE
TOP-QUALITY INHALATION THERAPHY

  • Micro Synchronized Delivery TechnologyTM (MSDT) atomizes a wide range of drugs.

  • Shorter nebulization time and higher delivery rate.

  • Smart design certifies leak-proof feature.

  • Biocompatibility test results guarantee patients' safety.

IT IS EASY TO USE FOR BOTH
ADULTS AND CHILDREN
Pulmogine® Vibrating Mesh Nebulizer Video

DOWNLOAD

  • Jun 14, 2024

    Pulmogine Vibrating Mesh Nebulizer Platform - Brochure

    15.87 MB
NEXT PRODUCT